Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07663292 · ClinicalTrials.gov registry record · NA

Neuroplastic Changes Due to an Exercise Intervention That Aid in Lower Limb Recovery After Subcortical Stroke

A NA study, sponsored by Emory University.

Not yet
Registry status
NA
Development phase
55
Enrollment target

NCT07663292 is a NA study that has not yet begun recruiting, run by Emory University. The registered enrollment target is 55 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07663292, a NA study, has not yet begun recruiting, sponsored by Emory University.

NOT YET RECRUITING
Registry status
NA
Development phase
55 participants
Enrollment target

Study Summary

This study aims to develop imaging-based biomarkers to assess which chronic stroke participant with lower extremity disability may respond or resist high intensity interval training (HIIT). Previous research suggests that physical exercise training is safe and could help improve the walking speed of non-ambulatory stroke survivors. However, inter-individual variability in response to exercise is extraordinarily high regardless of adherence, and predictors of response remain elusive. Chronic stroke survivors with lower limb disability resulting in slow walking speeds will participate in 12 weeks of cycling exercise at Emory University under the guidance of a physical exercise instructor, 3 days a week, for 25-60 minutes. During some of the exercise sessions, the investigators will collect blood lactate with a finger prick. Brain scans with an MRI before and after the 12 weeks of exercise will be done; motor function tests that include walking, sitting down, standing up, and turning around will be collected. Participants' memory and thinking will be assessed, and participants will fill out questionnaires about their health before and after their stroke, and well as questions about their diet. The participation will last between 14-16 weeks (up to 42 study visits).

Interventions

  • BEHAVIORAL HIIT intervention

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2026-07
Est. Completion 2027-03
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT07663292

The ClinicalTrials.gov registry entry for NCT07663292 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which HIIT intervention is the first listed.

NCT07663292 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07663292 about?

NCT07663292 is a clinical study titled "Neuroplastic Changes Due to an Exercise Intervention That Aid in Lower Limb Recovery After Subcortical Stroke". This study aims to develop imaging-based biomarkers to assess which chronic stroke participant with lower extremity disability may respond or resist high intensity interval training (HIIT). Previous research suggests that physical exercise training is safe and could help improve the walking speed o...

What is the current status of trial NCT07663292?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 55 participants. The study started on 2026-07. Estimated completion is 2027-03.

What interventions are being tested in trial NCT07663292?

The interventions under investigation include: HIIT intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT07663292?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.